Dawn Lobban is Scientific Division Lead at Alligent EU, one of the medical communications agencies within the Envision Pharma Group. In addition, she heads up the Envision the Patient Plain Language Team. With a strong background in scientific publications, Dawn is particularly interested in optimal patient involvement in medical communications. She has authored a number of abstracts at ISMPP (International Society for Medical Publication Professionals) and sits on the ISMPP EU meeting committee.